Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Self-Retired who wrote (46392)	11/11/1999 5:29:00 PM
From: charles shaw	Read Replies (1) of 122087

I don't understand this announcement. "Altace" is the brand name for the drug ramipril, manufactured by Hoechst Marion Roussel. It is an ACE inhibitor. This class of drug has been shown to be very effective in lowering blood pressure, protecting kidneys from diabetes, protecting the heart after a myocardial infarction, and prolonging life in patients with congestive heart failure. These benefits are thought to be class specific and not drug specific; in other words, all ACES are thought to have these benefits (there are about 10 of them). Does King manufacture generic drugs-- is ALTACE about to go off patent? That would be bigger news than another study confirming what physicians already know well.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next